ClinicalTrials.gg
RecruitingNCT06252480Updated Feb 9, 2024

Effect of Various Intensities of tDCS on Dual Task Cognitive Functions in Normal Subjects

An interventional study of tDCS in Cognitive Functions, sponsored by Maharishi Markendeswar University (Deemed to be University). Recruiting at 1 site in India. Open to participants aged 18 Years to 26 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-09.

Sponsored by Maharishi Markendeswar University (Deemed to be University) · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2024, 2 years 9 months ago, but the record still lists the study as recruiting.
  • Registered 6 months after the study started (first participant enrolled Aug 2023, registered Feb 2024).
  • Started Aug 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Not applicable
Ages
18 Years to 26 Years
Sex
All
01

Study summary

Transcranial Direct Current Stimulation (tDCS) is a neuroregulatory method that delivers a weak straight tendency to neuronal areas with the intention of changing the brain's basic metabolic processes. Degradation of executive performance may not necessarily arise from cathodal stimulation, and vice versa for anodal stimulation.

Read the detailed description

Total 48 samples were taken, were randomly allocated into an experimental group of 4 variance of different intensities of tDCS. At F3 and F4, tDCS was applied to the desired region. Electrodes were put in using the 10-20 EEG technique throughout the parietal cortex, with the current electrode being set on F3 area and control electrode being positioned on the F4 area. For 20 minutes over three days per week for up to three weeks, current intensities of 0.5mA for group A, 1.0mA for group B, 1.5mA for group C, and 2.0mA for group D were administered. when engaging in dual-task cognitive processes. The groups are going to receive 9 sessions of tDCS treatment. The MoCA and TMT scale was completed by samples before and after the intervention. Finally, specifics investigation will be carried out using SPSS 26.0 software.

02

Conditions studied

  • Cognitive Functions
03

In context

Lead sponsor

Maharishi Markendeswar University (Deemed to be University) is the lead sponsor of 41 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 26 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Physically healthy students only
  • Willing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Any recent trauma or injury on the head of subjects
  • If contact with the scalp is not possible
  • Any resonant implant close to electrode placement site
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Intensities of tDCS and dual task cognitive functions

    We have done in a one arm type. The participants are divided into different intensity group (0.5 mA, 1.0 mA, 1.5 mA and 2.0 mA).

    Device: tDCS

Interventions

  • DevicetDCS

    4 variance of different intensities of tDCS (0.5mA, 1 mA, 1.5mA and 2mA). At F3 and F4, tDCS was applied to the desired region. Electrodes were put in using the 10-20 EEG technique throughout the parietal cortex, with the current electrode being set on F3 area and control electrode being positioned on the F4 area. For 20 minutes over three days per week for up to three weeks, current intensities of 0.5mA for group A, 1.0mA for group B, 1.5mA for group C, and 2.0mA for group D were administered. when engaging in dual-task cognitive processes. The groups are going to receive 9 sessions of tDCS treatment.

06

What researchers measure

Primary outcomes

  1. MoCA

    A quick test for minor cognitive impairment. It evaluates a variety of cognitive processes, including executive functioning, recall, speech and direction. The assessment has 30 points and requires 10 mins to finish for each person. A typical result is that 26 and more is normal.

    Time frame: 10 mins

Secondary outcomes

  1. TRAIL MAKING TEST

    TMT part A includes 25 rounds containing the digits 1 to 25 scribbled haphazardly within every round on a sheet of paper. TMT part B similarly includes 25 rounds on a sheet of paper, but this rounds includes digits (1-12) and alphabet (A-L) instead of only being digits.

    Time frame: 3 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06252480
Lead sponsor
Maharishi Markendeswar University (Deemed to be University)
Responsible party
Subhasish Chatterjee (Effect of various intensities of tDCS on dual task cognitive functions in normal subjects: A Pilot Study, Maharishi Markendeswar University (Deemed to be University)) — Principal investigator
First posted
Feb 9, 2024
Start date
Aug 1, 2023
Primary completion
Feb 10, 2024 (estimated)
Completion
Mar 10, 2024 (estimated)
Last update
Feb 9, 2024

Study contacts

Elina Osik, BPT
Contact
elinaosik18@gmail.com
7629956147
Elina Osik, BPT
Contact
elinaosik@gmail.com
7629956147
Subhashish Chatterjee, MPT(NEURO)
principal investigator · Maharishi Markendeshwar Institute of Physiotherapy and Rehabilitation, Ambala, Haryana, 133207

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion